New mass spec test could spot lyme disease faster
NCT ID NCT02414789
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 33 times
Summary
This study tested a new diagnostic method (mass spectrometry) to detect Lyme disease bacteria in skin biopsies from 84 people with early Lyme rash (erythema migrans). The new method was compared to standard PCR and culture tests. The goal was to see if the new technique could identify the bacteria more often than existing methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHEMA MIGRANS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier William Morey
Chalon-sur-Saône, France
-
Centre Hospitalo-Universitaire Jean Minjoz
Besançon, France
-
Hôpital Bel Air
Thionville, France
-
Hôpital E. Muller
Mulhouse, France
-
Hôpital Pasteur
Colmar, France
-
Hôpital Robert Debré
Reims, France
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a faster, more accurate diagnostic test for early Lyme disease.
What could go wrong
This is a small, completed study testing a new method against existing ones. The new test may not prove more sensitive or practical for routine use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.